Carilion Mental Health
Roanoke, Virginia, 24018, United States
NCT Number: NCT06671158
Although measurement-based care (MBC) is an evidence-based practice with known benefits, it is not always systematically implemented with fidelity. Questions remain regarding MBC's unique added value compared to usual care.
Thus, the goal of this clinical trial is to investigate the implementation outcome, effectiveness, and mechanisms of change of measurement-based care in adult behavioral health. This study implemented MBC in adult ambulatory behavioral health and will test outcomes using a pragmatic randomized control trial within the RE-AIM (Reach, Efficacy, Adoption, Implementation, and Maintenance) framework.
Researchers will compare three groups: 1) the Measurement-based care group, 2) the treatment-as-usual group, and 3) the waitlist control group. Participants will participate in weekly individual psychotherapy sessions for 12 sessions in total.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Interventional
Not applicable
Roanoke, Virginia, 24018, United States
Measurement-based care (MBC) is an evidenced-based practice, involving routine completion of patient-reported outcome measures and collaborative discussions between clinician and client to inform clinical decision-making and facilitate improvement. Despite its known benefits, such as reduced dropout rates and improved treatment outcomes, questions remain regarding MBC's unique effectiveness compared to standard care. Furthermore, mechanisms of change on how MBC actually works in treatment have yet to be fully investigated. Thus, the current study aims to conduct a randomized control trial to evaluate the added value of MBC, by comparing an MBC+psychotherapy group, a psychotherapy-only group, and a waitlist group with no interventions.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Individual psychotherapy for weekly 12-sessions
Time frame: Completed weekly through study completion, an average of 3 to 4 months
Self-report questionnaire designed to measure general psychological adjustment and functioning of adult-aged individuals Minimum score: 6 Maximum score: 42 A higher score indicates severe difficulty in psychological adaptation and functioning/worse outcome
Time frame: Completed weekly through study completion, an average of 3 to 4 months
Evaluate depression symptoms Minimum score: 0 Maximum score: 27 A higher score indicates more severe depression/worse outcome
Time frame: Completed weekly through study completion, an average of 3 to 4 months
evaluate anxiety symptoms Minimum score: 0 Maximum score: 21 A higher score indicates more severe anxiety/worse outcome
Time frame: Pre-post, through study completion, an average of 3 to 4 months
This is a self-report measure designed to assess an individual's quality of life and well-being across four domains, including physical health, psychological well-being, social relationships, and environmental conditions Minimum score: 0 Maximum score: 100 A higher score indicates a higher quality of life/better outcome
Time frame: Completed monthly, through study completion, an average of 3 to 4 months
The WAI-SR is a self-report measure of the strengths of the therapeutic alliance that clients perceive.
Minimum score: 12 Maximum score: 60 A higher score indicates a stronger working alliance between the provider and the patient / better outcome
Time frame: Completed every 6 weeks; through study completion, an average of 3 to 4 months
The VPPS-P is a patient-report measure consisting of 42 items with five subscales, including therapist exploration, negative relationship, patient psychic distress, patient participation, therapist warmth and friendliness, and patient dependency.
Minimum score: 42 Maximum score: 210 A higher score indicates better outcome
Time frame: Pre-post, through study completion, an average of 3 to 4 months
Clinical impressions of the clinician's view on the client's global functioning, the overall severity of symptoms (CGI-S) Minimum score: 1 Maximum score: 7 A higher score indicates more severe impairment/worse outcome
Time frame: Pre-post, through study completion, an average of 3 to 4 months
As CGI-S, the PGI-S is a 1-item global impression questionnaires that allow patients to report their own views on the severity of ongoing symptoms based on a 7-point scale Minimum score: 1 Maximum score: 7 A higher score indicates more severe impairment/worse outcome
Time frame: Through study completion, an average of 3 to 4 months
Clinical impressions of the client's improvement level that the client shows throughout the therapy (CGI-I) Minimum score: 1 Maximum score: 7 A lower score indicates better outcome
Time frame: Through study completion, an average of 3 to 4 months
PGI-S is a 1-item global impression questionnaires that allow patients to report their own views on the response and improvement to intervention based on a 7-point scale Minimum score: 1 Maximum score: 7 A lower score indicates better outcome
Time frame: Through study completion, an average of 3 to 4 months
A 12-item tailored questionnaire was created to fully capture clients' attitudes towards and experience with measurement-based care during their treatment.
Minimum value: 12 Maximum value: 60 Higher score indicates better outcome/more positive attitudes toward measurement-based care
Carilion Clinic
Other
An Evaluation of the Effectiveness and Mechanisms of Change of Measurement Based Care for Depressive and Anxiety Disorders
Acronym: MBC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05400252
Anxiety Disorders, Behavior
Aurora, Colorado, United States
View Trial DetailsNCT06440460
Anxiety Disorders, Anxiety State
Freetown, Sierra Leone
View Trial DetailsNCT03250026
Anxiety Disorders, Depressive Disorder
Gothenburg, Region Västra Götaland, Sweden
View Trial DetailsNCT05551468
Anxiety Disorders, Behavior
Boekel, Netherlands
View Trial Details